Tue, Apr. 28, 12:45 PM
Tue, Apr. 28, 10:45 AM
- Stepan (SCL +13.2%) soars after topping the consensus Q1 EPS mark by a healthy margin.
- Volume was up 2% during the period and F/X cut six percentage points off of growth.
- The company made strides with cost cutting as the selling expense category fell 8.1% Y/Y to $12.997M.
- Previously: Stepan beats by $0.33, misses on revenue
Dec. 17, 2012, 12:45 PM
SCL vs. ETF Alternatives
Stepan Co along with its subsidiaries produces specialty and intermediate chemicals, which are sold to other manufacturers and are used in end products. The Company manufactures & markets surfactants, polymers and specialty products.
Other News & PR